February 27, 2020 / 9:15 PM / a month ago

BRIEF-Spectrum Pharmaceuticals Posts Q4 Loss Per Share Of $0.36

Feb 27 (Reuters) - Spectrum Pharmaceuticals Inc:

* SPECTRUM PHARMACEUTICALS REPORTS FOURTH QUARTER 2019 AND FULL YEAR 2019 FINANCIAL RESULTS AND PIPELINE UPDATE

* Q4 NON-GAAP LOSS PER SHARE $0.30

* Q4 LOSS PER SHARE $0.36

* Q4 EARNINGS PER SHARE ESTIMATE $-0.33 — REFINITIV IBES DATA

* EXPECTS THAT SG&A EXPENSE WILL INCREASE IN H2 OF THIS YEAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below